Lilly completes acquisition of immuno-oncology firm Armo BioSciences

pallavi123- June 24, 2018 0

Strategic Expansion in Cancer Treatment: Eli Lilly and Company (Lilly), a leading US pharmaceutical firm, has finalized its acquisition of Armo BioSciences, a California-based immuno-oncology ... Read More

Roche set to fully acquire Flatiron Health in $1.9bn deal to accelerate cancer drug development

pallavi123- February 16, 2018 0

Roche, the Swiss pharmaceutical giant, has announced its plans to fully acquire Flatiron Health, a leading oncology software company, for $1.9 billion. This strategic move ... Read More